Evolution of uterine adenomyosis volume during and after GnRH antagonist (linzagolix) treatment: lessons for further clinical trials

Fertil Steril. 2023 Nov;120(5):1071-1073. doi: 10.1016/j.fertnstert.2023.07.012. Epub 2023 Jul 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenomyosis* / drug therapy
  • Carboxylic Acids
  • Female
  • Gonadotropin-Releasing Hormone
  • Humans
  • Pyrimidines / therapeutic use

Substances

  • linzagolix
  • Gonadotropin-Releasing Hormone
  • Carboxylic Acids
  • Pyrimidines